Furthermore, Galectin-3 showed direct bacteriostatic properties against Streptococcus pneumonia in vitro, while recombinant Galectin-3 decreased severity of pneumonia in Galectin-3 deficient mice [40]. This evidence concerns the gene LGALS3 and pneumonia.